Literature DB >> 25393399

Platelets and fibrin in progression of liver disease: friends or foes?

T Lisman1.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 25393399     DOI： 10.1111/jth.12783

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN： 1538-7836            Impact factor:   5.824


× No keyword cloud information.
  3 in total

1.  Changing common sense: Anti-platelet/coagulation therapy against cirrhosis.

Authors:  Yoshihiro Ikura; Tatsuya Osuga
Journal:  World J Hepatol       Date:  2015-07-08

2.  Inhibition of PAR-4 and P2Y12 receptor-mediated platelet activation produces distinct hepatic pathologies in experimental xenobiotic-induced cholestatic liver disease.

Authors:  Nikita Joshi; Anna K Kopec; Jessica L Ray; James P Luyendyk
Journal:  Toxicology       Date:  2016-07-27       Impact factor: 4.221

3.  Molecular Magnetic Resonance Imaging of Fibrin Deposition in the Liver as an Indicator of Tissue Injury and Inflammation.

Authors:  Iliyana Atanasova; Mozhdeh Sojoodi; Helena S Leitão; Sergei Shuvaev; Carlos F G C Geraldes; Ricard Masia; Alexander S Guimaraes; Kenneth K Tanabe; Bryan C Fuchs; Peter Caravan
Journal:  Invest Radiol       Date:  2020-04       Impact factor: 6.016
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.